Calc Function

    • Calcs that help predict probability of a diseaseDiagnosis
    • Subcategory of 'Diagnosis' designed to be very sensitiveRule Out
    • Disease is diagnosed: prognosticate to guide treatmentPrognosis
    • Numerical inputs and outputsFormula
    • Med treatment and moreTreatment
    • Suggested protocolsAlgorithm

    Disease

    Select...

    Specialty

    Select...

    Chief Complaint

    Select...

    Organ System

    Select...

    Patent Pending

    Log In

    Show
    Forgot your password?
    Log In
    Or create a new account (it's free)

    Forgot Password?

    Enter your email address and we'll send you a link to reset your password.

    Get New Password

    Sign In Required

    To save favorites, you must log in.

    Creating an account is free, easy, and takes about 60 seconds.

    Already have an MDCalc account?

    Login to link your favorites and recently used calcs

    Show
    Forgot your password?
    Log In
    Or continue to Nuance

    Attention COACH STUDY participants:

    The principal investigators of the study request that you use the official version of the modified score here.

    MuLBSTA Score for Viral Pneumonia Mortality

    Predicts 90-day mortality in patients with viral pneumonia.

    IMPORTANT

    Launched during COVID-19 crisis. Not externally validated. Use with caution.

    Tips for COVID-19: Use after diagnosis to determine dispo. Specific for Viral PNA and similar inputs as known COVID-19 mortality risk factors, but not externally validated.

    When to Use
    Pearls/Pitfalls
    Why Use

    In patients with viral pneumonia, to predict clinical characteristics that affect mortality.

    • Designed specifically for viral pneumonia, which may account for up to 29% of CAP (Jennings 2008).

    • Virus-associated pneumonia is defined as lower respiratory infection with a positive PCR for viral antigen.

    • This single-center, retrospective, not-externally-validated design may lead to bias and unknown applicability and generalizability.

    • If used on COVID-19 PNA patients, keep in mind that age has a much stronger odds ratio for increasing mortality risk in COVID-19 patients than with other viral PNA patients.

    • Predicts risk factors for mortality that may be unique to viral PNA.

    • The MuLBSTA score examines a patient population with similar characteristics to those with COVID-19 PNA, and has inputs similar to risk factors for mortality seen in the initial COVID-19 patient cohorts out of China.

    No
    0
    Yes
    +5
    No
    0
    Yes
    +4
    No
    0
    Yes
    +4
    Non smoker
    0
    Prior smoker
    +2
    Active smoker
    +3
    No
    0
    Yes
    +2
    No
    0
    Yes
    +2
    Confirmed positive
    Suspected
    Unlikely
    Confirmed negative

    Result:

    Please fill out required fields.

    Next Steps
    Evidence
    Creator Insights
    Dr. Xinxin Zhang

    About the Creator

    Xinxin Zhang, MD, PhD, is a professor of infectious diseases at Shanghai Jiao Tong University in China. She is also vice chairman of the Shanghai Hepatology Society and has published over 160 papers, with contributions to journals like Gut and the Journal of Clinical Microbiology. Dr. Zhang’s primary research is focused on the pathology and treatment of various infectious diseases such as hepatitis and viral pneumonia.

    To view Dr. Xinxin Zhang's publications, visit PubMed

    Are you Dr. Xinxin Zhang? Send us a message to review your photo and bio, and find out how to submit Creator Insights!
    MDCalc loves calculator creators – researchers who, through intelligent and often complex methods, discover tools that describe scientific facts that can then be applied in practice. These are real scientific discoveries about the nature of the human body, which can be invaluable to physicians taking care of patients.
    Content Contributors
    About the Creator
    Dr. Xinxin Zhang
    Are you Dr. Xinxin Zhang?
    Also from MDCalc...
    Content Contributors